HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroharu Yamashita Selected Research

Gemcitabine

1/2021A phase I study of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel for pancreatic cancer with peritoneal metastasis.
9/2014Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroharu Yamashita Research Topics

Disease

58Stomach Neoplasms (Stomach Cancer)
12/2022 - 11/2004
45Neoplasms (Cancer)
01/2022 - 11/2004
23Neoplasm Metastasis (Metastasis)
12/2022 - 10/2005
13Carcinoma (Carcinomatosis)
01/2021 - 11/2005
9Ascites
01/2017 - 01/2010
7Lymphatic Metastasis
07/2022 - 10/2005
6Sarcopenia
05/2022 - 01/2020
5Esophageal Squamous Cell Carcinoma
07/2022 - 10/2016
5Esophageal Neoplasms (Esophageal Cancer)
09/2021 - 01/2016
5Adenocarcinoma
03/2021 - 10/2005
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 09/2005
2Obesity
04/2021 - 06/2020
2Pneumonia (Pneumonitis)
03/2021 - 10/2016
2Flatulence
02/2021 - 08/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 09/2014
2Wounds and Injuries (Trauma)
08/2018 - 01/2010
2Vomiting
01/2018 - 01/2010
2Colonic Neoplasms (Colon Cancer)
05/2006 - 09/2005
1Abdominal Abscess
06/2022
1Pneumothorax
06/2022
1Duodenal Neoplasms (Duodenal Cancer)
01/2022
1Esophageal Fistula
07/2021
1Residual Neoplasm
07/2021
1Pancreatic Fistula (Pancreatic Fistulas)
03/2021
1Neuroendocrine Carcinoma
02/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Avitaminosis (Vitamin Deficiency)
11/2018
1Infections
01/2018

Drug/Important Bio-Agent (IBA)

13Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 12/2008
7Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2006
7lysophosphatidic acidIBA
01/2017 - 12/2004
5Indicators and Reagents (Reagents)IBA
02/2022 - 03/2007
5ErbB Receptors (EGF Receptor)IBA
09/2008 - 11/2004
4Biological ProductsIBA
01/2022 - 01/2006
4Coloring Agents (Dyes)IBA
10/2020 - 06/2007
3C-Reactive ProteinIBA
02/2021 - 10/2005
3Hyaluronic Acid (Hyaluronan)IBA
01/2014 - 06/2007
3Fibrinogen (Factor I)FDA Link
06/2009 - 10/2005
2AntigensIBA
01/2022 - 01/2018
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
2RNA (Ribonucleic Acid)IBA
05/2021 - 01/2020
2B7-H1 AntigenIBA
02/2021 - 01/2021
2Programmed Cell Death 1 ReceptorIBA
02/2021 - 01/2017
2GemcitabineFDA Link
01/2021 - 09/2014
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2020 - 12/2015
2Phospholipases A1 (Phospholipase A1)IBA
01/2017 - 03/2015
2LysophospholipidsIBA
01/2017 - 02/2005
2PhosphatidylserinesIBA
01/2017 - 03/2015
2RacivirIBA
01/2014 - 08/2013
2Indigo Carmine (Indigo Blue)IBA
01/2014 - 06/2009
2Aligeron (AS 2)IBA
01/2010 - 01/2009
2Peptide Hormones (Polypeptide Hormones)IBA
09/2008 - 07/2007
2Phosphotransferases (Kinase)IBA
09/2008 - 09/2005
2Lysophosphatidic Acid ReceptorsIBA
01/2006 - 12/2004
2LigandsIBA
02/2005 - 11/2004
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
02/2005 - 11/2004
1taxaneIBA
12/2022
1PlatinumIBA
12/2022
1Hematoxylin (Haematoxylon)IBA
01/2022
1Eosine Yellowish-(YS) (Eosin)IBA
01/2022
1CarbohydratesIBA
01/2022
1NivolumabIBA
11/2021
1CytokinesIBA
03/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2021
1130-nm albumin-bound paclitaxelIBA
01/2021
1Carmine (Natural Red 4)IBA
10/2020
14-azidosalicylic acid-phosphatidylserineIBA
09/2020
1pembrolizumabIBA
01/2020
1N-acetyltalosaminuronic acid (NAT)IBA
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1Immune Checkpoint ProteinsIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Deoxyribonuclease I (Nickase)IBA
12/2018
1IronIBA
11/2018
1Analgesics (Analgesic Drugs)IBA
08/2018

Therapy/Procedure

22Gastrectomy
05/2022 - 11/2005
20Drug Therapy (Chemotherapy)
12/2022 - 07/2009
12Esophagectomy
07/2022 - 08/2011
10Therapeutics
12/2022 - 04/2014
10Lymph Node Excision (Lymph Node Dissection)
07/2021 - 01/2010
5Adjuvant Chemotherapy
12/2022 - 06/2009
4Combination Drug Therapy (Combination Chemotherapy)
03/2017 - 05/2012
3Operative Surgical Procedures
01/2022 - 01/2016
2Appendectomy
06/2022 - 01/2010
2Neoadjuvant Therapy
02/2022 - 09/2019
2Pancreaticoduodenectomy
01/2022 - 03/2021
2Radiotherapy
07/2021 - 08/2017
2Chemoradiotherapy
07/2021 - 04/2020
2Length of Stay
03/2021 - 12/2017
2Laparotomy
12/2018 - 01/2014
2Catheters
01/2014 - 08/2013
1Cholecystectomy
06/2022
1Transjugular Intrahepatic Portasystemic Shunt
06/2022
1Photochemotherapy (Photodynamic Therapy)
07/2021
1Salvage Therapy
07/2021
1Contraindications
07/2021
1Metastasectomy
07/2021
1Renal Dialysis (Hemodialysis)
01/2021
1Splenectomy
09/2019
1Immunotherapy
04/2018